A Delaware jury has failed to reach a verdict in the high-stakes legal battle between Qualcomm and Arm Holdings. The case involves allegations of contract breaches, with potential impacts on billions in royalty payments and future licensing deals.
The federal jury in the legal confrontation between Qualcomm and Arm Holdings in Delaware has failed to reach a verdict after five days of trial proceedings. The court has paused deliberations, which are now scheduled to resume on Tuesday, October 13, 2026.
At the heart of the dispute are Qualcomm’s allegations that Arm breached its licensing agreements. Qualcomm contends that Arm acted in bad faith by withholding essential chip-testing tools and leaking a 2024 license-termination threat. According to Qualcomm, these actions were designed to sabotage its business relationships, particularly its partnership with Meta Platforms.
Arm Holdings has contested these claims, asserting that the lawsuit is a strategic move by Qualcomm to gain leverage in separate, contentious negotiations over future licensing terms. During the trial, Arm's representatives argued that Qualcomm failed to provide evidence of tangible financial harm caused by the contested actions. Arm’s management has maintained that the friction is a result of evolving business models within the semiconductor industry, rather than a contractual violation.
For investors, the most significant monitorable is the potential financial impact of the court’s ruling. Qualcomm is seeking relief that could allow it to suspend royalty payments to Arm for up to five years. If granted, this could involve billions of dollars, significantly affecting the revenue stability of Arm and the cost structure of Qualcomm. However, the outcome remains uncertain as Judge Maryellen Noreika is currently weighing whether to strike the specific contractual provision that would allow for such a long-term suspension of payments.
The conflict highlights a broader shift in the semiconductor sector. Since SoftBank Group acquired Arm in 2016, the company has transitioned from a neutral technology licensor to a player that increasingly competes with its own licensees. This evolution has created tension with long-term partners like Qualcomm, which relies on Arm's architecture for its chip designs.
Investors should note that the jury trial is only one part of the ongoing legal pressure. A separate bench trial is concurrently assessing whether Arm negotiated in good faith regarding terms for future chip architectures. The final rulings from these proceedings could fundamentally change how licensing deals are structured and enforced in the industry, impacting the long-term operational costs and revenue visibility for both tech giants.